• Users Online: 21197
  • Home
  • Print this page
  • Email this page

    Article Cited by others

SYMPOSIUM - TRIP

Changing paradigms of anti-VEGF in the Indian scenario

Shanmugam P Mahesh

Year : 2014| Volume: 62| Issue : 1 | Page no: 88-92

   This article has been cited by
 
1 Role of Anti-Vascular Endothelial Growth Factor (Anti-VEGF) in the Treatment of Retinopathy of Prematurity: A Narrative Review in the Context of Middle-Income Countries
Mangat Ram Dogra, Anand Vinekar
Pediatric Health, Medicine and Therapeutics. 2023; Volume 14: 59
[Pubmed]  [Google Scholar] [DOI]
2 Efficacy and Cost-Effectiveness of Anti-VEGF for Treating Diabetic Retinopathy in the Indian Population
Subhasish Pramanik, Lakshmi Kanta Mondal, Suman Kalyan Paine, Sneha Jain, Subhankar Chowdhury, Upasana Ganguly, Sayantan Ghosh, Chiranjit Bose, Koena Bhattacharjee, Gautam Bhaduri
Clinical Ophthalmology. 2021; Volume 15: 3341
[Pubmed]  [Google Scholar] [DOI]
3 Klebsiella Cluster Endophthalmitis following Intravitreal Bevacizumab: Role of Early Detection, Pars Plana Vitrectomy, and Intracameral Moxifloxacin
Gaurav Mohan Kohli, Pratik Shenoy, Pawan Puneet Malhotra, Shubhi Tripathi, Sachin Shetty, Alok Sen
Ocular Immunology and Inflammation. 2020; : 1
[Pubmed]  [Google Scholar] [DOI]
4 Addressing risk factors, screening, and preventative treatment for diabetic retinopathy in developing countries: a review
Stephanie Lin, Pradeep Ramulu, Ecosse L Lamoureux, Charumathi Sabanayagam
Clinical & Experimental Ophthalmology. 2016; 44(4): 300
[Pubmed]  [Google Scholar] [DOI]
5 Translating research into practice
Natarajan, S.
Indian Journal of Ophthalmology. 2014; 62(1): 1-2
[Pubmed]  [Google Scholar]

 

Read this article